Oncogenic K-RAS subverts the antiapoptotic role of N-RAS and alters modulation of the N-RAS: Gelsolin complex

Oncogene

Volumn 26, Issue 21, 2007, Pages 3051-3059

  Keller, J W ^a   Haigis, K M ^b   Franklin, J L ^a   Whitehead, R H ^a   Jacks, T ^b   Coffey, R J ^a,c,d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Gelsolin; K RAS; N RAS; Survival

Indexed keywords

GELSOLIN; GUANOSINE TRIPHOSPHATE; K RAS PROTEIN; N RAS PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE MUTATION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; ONCOGENE K RAS; ONCOGENE N RAS; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CACO-2 CELLS; CELL LINE; CELL SURVIVAL; COLORECTAL NEOPLASMS; GELSOLIN; GENES, RAS; HCT116 CELLS; HUMANS; MICE; PROTO-ONCOGENE PROTEINS P21(RAS); RAS PROTEINS;

EID: 34248324359     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210103     Document Type: Article

References (39)

1. Apolloni A, Prior IA, Lindsay M, Parton RG, Hancock JF. (2000). H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway. Mol Cell Biol 20: 2475-2487.
2. Archer SY, Hodin A. (1999). Histone acetylation and cancer. Curr Opin Genet Dev 9: 171-174.
3. Bos JL. (1989). ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689.
4. Cantrell DA, Davies AA, Crumpton MJ. (1985). Activators of protein kinase C down-regulate and phosphorylate the T3/T-cell antigen receptor complex of human T lymphocytes. Proc Natl Acad Sci USA 82: 8158-8162.
5. Chiu VK, Bivona T, Hach A, Sajous JB, Silletti J, Wiener H et al. (2002). Ras signalling on the endoplasmic reticulum and the Golgi. Nat Cell Biol 4: 343-350.
6. Choy E, Chiu VK, Silletti J, Feoktistov M, Morimoto T, Michaelson D et al. (1999). Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell 98: 69-80.
7. Diaz R, Ahn D, Lopez-Barcons L, Malumbres M, Perez de Castro I, Lue J et al. (2002). The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. Cancer Res 62: 4514-4518.
8. Downward J. (2003). Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3: 11-22.
9. Downward J, Graves JD, Warne PH, Rayter S, Cantrell DA. (1990). Stimulation of p21 ras upon T-cell activation. Nature 346: 719-723.
10. Esteban LM, Vicario-Abejon C, Fernandez-Salguero P, Fernandez-Medarde A, Swaminathan N, Yienger K et al. (2001). Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol 21: 1444-1452.
11. Hamilton M, Wolfman A. (1998). Ha-ras and N-ras regulate MAPK activity by distinct mechanisms in vivo. Oncogene 16: 1417-1428.
12. Hamilton M, Liao J, Cathcart MK, Wolfman A. (2001). Constitutive association of c-N-Ras with c-Raf-1 and protein kinase C epsilon in latent signaling modules. J Biol Chem 276: 29079-29090.
13. Hancock JF. (2003). Ras proteins: different signals from different locations. Nat Rev Mol Cell Biol 4: 373-384.
14. Hancock JF, Cadwallader K, Paterson H, Marshall CJ. (1991). A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. EMBO J 10: 4033-4039.
15. Hancock JF, Magee AI, Childs JE, Marshall CJ. (1989). All ras proteins are isoprenylated but only some are palmitoylated. Cell 57: 1167-1177.
16. Hancock JF, Paterson H, Marshall CJ. (1990). A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21 ras to the plasma membrane. Cell 63: 133-139.
17. Johnson L, Greenbaum D, Cichowski K, Mercer K, Murphy E, Schmitt E et al. (1997). K-ras is an essential gene in the mouse with partial functional overlap with N-Ras. Genes Dev 11: 2468-2481.
18. Klampfer L, Huang J, Sasazuki T, Shirasawa S, Augenlicht L. (2004). Oncogenic Ras promotes butyrate-induced apoptosis through inhibition of gelsolin expression. J Biol Chem 279: 36680-36688.
19. Klampfer L, Swaby LA, Huang J, Sasazuki T, Shirasawa S, Augenlicht L. (2005). Oncogenic Ras increases sensitivity of colon cancer cells to 5-FU-induced apoptosis. Oncogene 24: 3932-3941.
20. Koera K, Nakamura K, Nakao K, Miyoshi J, Toyoshima K, Hatta T et al. (1997). K-ras is essential for the development of the mouse embryo. Oncogene 15: 1151-1159.
21. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K et al. (1997). Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278: 294-298.
22. Koya RC, Fujita H, Shimizu S, Ohtsu M, Takimoto M, Tsujimoto Y et al. (2000). Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release. J Biol Chem 275: 15343-15349.
23. Kusano H, Shimizu S, Koya RC, Fujita H, Kamada S, Kuzumaki N et al. (2000). Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial changes via closing VDAC. Oncogene 19: 4807-4814.
24. Matallanas D, Sanz-Moreno V, Arozarena I, Calvo F, Agudo-Ibanez L, Santos E et al. (2006). Distinct utilization of effectors and biological outcomes resulting from site-specific Ras activation: Ras functions in lipid rafts and Golgi complex are dispensable for proliferation and transformation. Mol Cell Biol 26: 100-116.
25. Ohtsu M, Sakai N, Fujita H, Kashiwagi M, Gasa S, Shimizu S et al. (1997). Inhibition of apoptosis by the actin-regulatory protein gelsolin. EMBO J 16: 4650-4656.
26. Prior IA, Hancock JF. (2001). Compartmentalization of Ras proteins. J Cell Sci 114: 1603-1608.
27. Prior IA, Muncke C, Parton RG, Hancock JF. (2003). Direct visualization of Ras proteins in spatially distinct cell surface microdomains. J Cell Biol 160: 165-170.
28. Rocks O, Peyker A, Kahms M, Verveer PJ, Koerner C, Lumbierres M et al. (2005). An acylation regulates localization and activity of palmitoylated Ras isoforms. Science 307: 1746-1752.
29. Roy S, Luetterforst R, Harding A, Apolloni A, Etheridge M, Stang E et al. (1999). Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domain. Nat Cell Biol 1: 98-105.
30. Roy S, Plowman S, Rotblat B, Prior IA, Muncke C, Grainger S et al. (2005). Individual palmitoyl residues serve distinct roles in h-ras trafficking, microlocalization, and signaling. Mol Cell Biol 25: 6722-6733.
31. Shirasawa S, Furuse M, Yokoyama N, Sasazuki T. (1993). Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260: 85-88.
32. Umanoff H, Edelmann W, Pellicer A, Kucherlapati R. (1995). The murine N-ras gene is not essential for growth and development. Proc Natl Acad Sci USA 92: 1709-1713.
33. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M et al. (1988). Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532.
34. White MA, Nicolette C, Minden A, Polverino A, Van Aelst L, Karin M et al. (1995). Multiple Ras functions can contribute to mammalian cell transformation. Cell 80: 533-541.
35. Whitehead RH, Brown A, Bhathal PS. (1987). A method for the isolation and culture of human colonic crypts in collagen gels. In vitro Cell Dev Biol 23: 436-442.
36. Willumsen BM, Christensen A, Hubbert NL, Papageorge AG, Lowy DR. (1984). The p21 ras C-terminus is required for transformation and membrane association. Nature 310: 583-586.
37. Wolfman JC, Wolfman A. (2000). Endogenous c-N-Ras provides a steady-state anti-apoptotic signal. J Biol Chem 275: 19315-19323.
38. Wolfman JC, Palmby T, Der CJ, Wolfman A. (2002). Cellular N-Ras promotes survival by downregulation of Jun N-terminal protein kinase and p38. Mol Cell Biol 22: 1589-1606.
39. Yin HL, Stossel TP. (1979). Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatorty protein. Nature 281: 583-586.